Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Advisors Asset Management Inc.

Advisors Asset Management Inc. decreased its position in Amedisys, Inc. (NASDAQ:AMED) by 15.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,289 shares of the health services provider’s stock after selling 235 shares during the quarter. Advisors Asset Management Inc.’s holdings in Amedisys were worth $124,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SG Americas Securities LLC raised its position in shares of Amedisys by 413.4% in the third quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock valued at $18,985,000 after buying an additional 158,398 shares during the last quarter. Highbridge Capital Management LLC grew its stake in Amedisys by 34.7% in the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock worth $29,670,000 after acquiring an additional 83,200 shares during the period. Murchinson Ltd. raised its holdings in Amedisys by 69.2% in the 2nd quarter. Murchinson Ltd. now owns 123,979 shares of the health services provider’s stock valued at $11,381,000 after acquiring an additional 50,716 shares during the last quarter. Calamos Advisors LLC lifted its stake in shares of Amedisys by 11.6% during the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock worth $36,476,000 after purchasing an additional 41,220 shares during the period. Finally, Canada Pension Plan Investment Board boosted its holdings in shares of Amedisys by 61.0% during the second quarter. Canada Pension Plan Investment Board now owns 79,200 shares of the health services provider’s stock worth $7,271,000 after purchasing an additional 30,000 shares during the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Price Performance

Shares of NASDAQ:AMED opened at $91.41 on Friday. The business has a fifty day simple moving average of $94.86 and a 200-day simple moving average of $95.64. Amedisys, Inc. has a 52 week low of $88.81 and a 52 week high of $98.95. The company has a market cap of $2.99 billion, a P/E ratio of 36.40, a P/E/G ratio of 1.92 and a beta of 0.78. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company’s revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.98 EPS. Equities research analysts forecast that Amedisys, Inc. will post 4.55 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.